再障饮配合西药治疗再生障碍性贫血临床观察

目的：研究中药复方再障饮对慢性再生障碍性贫血患者免疫功能的影响。方法：测定再障饮治疗前后患者T淋巴细胞亚群、血清肿瘤坏死因子(TNF-α)、白细胞介素-2(IL-2)的水平，并用常规治疗组和正常组做对照分析其变化规律。结果：再障饮治疗前CD4明显降低、CD8升高、CD4/CD8降低；TNF-α、IL-2均升高，与正常组比较差异有显著性(P<0．05)。再障饮治疗后CD4升高、CD8降低、CD4／CD8升高；TNF-α、IL-2均降低，与治疗前及对照组比较差异均有显著性(P

Clinical Observation on Treatment of Aplastic Anemia Patients by Zaizhang Decoction Combined with Western Medicine

OBJECTIVE: To study the effect of Composite Zaizhang decoction (ZZD) on immune function of chronic aplastic anemia (CAA) patients. METHODS: To determine the levels of T-lymphocyte subset, serum tumor necrosis factor (TNF-alpha) and interleukin-2 (IL-2) in CAA patients before and after treatment, and to analyse the regulation of their changes comparatively with the group treated with conventional treatment and a normal control group. RESULTS: Before treatment, CD4 was lower, CD8 higher, CD4/CD8 ratio also lower, TNF-alpha and IL-2 were higher in the ZZD treated group than those in the normal control group, with significant difference (P < 0.05), but after ZZD treatment, these indexes were all inversely changed, as compared with those before treatment and with those in the control group, the difference was significant (P < 0.05). CONCLUSION: ZZD might relieve the hemopoietic inhibition so as to promote the recovery of hemopoietic function through improving the T-lymphocyte subset and reducing the release of hemopoietic negative ragulatory factors such as TNF-alpha and IL-2 etc.